Published: 03/02/2026
Xience 28/90
The XIENCE™ stent has a low ST rate and is significantly less thrombotic than other DES (drug-eluting stents). (1,3)
When it comes to percutaneous coronary interventions (PCI), small differences between stents can be a determining factor in whether clinical success is temporary or optimal in both the short and long term.
XIENCE™ 28
The XIENCE™ stent for 1-month DAPT showed no increase in ischemic events compared to 6-month DAPT – all deaths or MI.1
XIENCE 28 included more than 1,600 patients at high risk of bleeding.1
The XIENCE™ stent for 1-month DAPT had a significantly lower incidence of major bleeding compared to 6-month DAPT (BARC 3-5).1
XIENCE™ 90
The XIENCE™ stent with 3-month DAPT showed no increase in ischemic events compared to 12-month DAPT – all deaths or MI.1
XIENCE 90 included more than 2,000 patients at high risk of bleeding.1
The XIENCE™ stent with 3-month DAPT had a significantly lower incidence of major bleeding compared to 12-month DAPT (BARC 3-5).1
For BARC 2-5, the XIENCE™ stent with 3-month DAPT showed a numerically lower bleeding rate compared to 12-month DAPT.1
For more information about this study, see the XIENCE™ Sierra product section under Downloads:
1. Mehran R, et al. TCT Connect 2020 – XIENCE 28 & XIENCE 90
3. Jinnouchi H, et al. J Am Coll Cardiol. 2019;74:Suppl B – TCT-291.
